GSK Stock Price and Chart — NYSE:GSK — TradingView

Compare with GSK plc

Key facts today

GSK plans about $30 billion in U.S. R&D and manufacturing investment over five years to expand its U.S. R&D, production and supply-chain capacity.

GSK plc (GSK) said ordinary shares were admitted to trading on 6 Oct 2026 under existing block listings tied to its Share Save Plan 2022, per Company Secretary V.A. Whyte.

Analyze the impact Analyze the impact

Key stats

Upcoming earnings

Company info

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

GSK - Long -TGT 2482 GSK stock has been strengthening. for the last periods. The stock is expected to hit the levels of 2482 as per the technical analysis. The stock has already hit the support levels at 1825. Its expected to blast out of the triangle and move higher. However , the stock has goos support at the levels o

by Investing_Trading

GSK | Powerful Move Going Into 2026 | LONG GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three prod

by DivergenceSeeker

GSK Breakout Trade – Clean Setup Ahead Pattern: Bullish breakout from descending wedge Entry Zone: Around $4.83–$4.97 Stop Loss: Just below $4.70 (trendline + horizontal support) Target: $5.18 (green resistance level)

by ProfittoPath

$GSK A potential "ABC" pattern has been located here at a level where two previous support levels were broken. Price is near the 11-2023 support level. Looking for a retracement here to two targets overtime.

GSK 1-2 wk swing Idea NYSE:GSK has set of a daily trigger with a 5/10 ema crossover after a positive earnings report. During my planning for this idea, I needed to zoom WAY out to the monthly chart in order to understand these levels a bit more. Screen shot of the monthly below: It turns out that last week's close

by D_Rockefeller

GSK Not a recommendation. Held this for a while with very little movement, now GSK as started going up, div yield is over 3.3%

by tradologist10

Long GSK - Euro Drug Hype Cycle approaches Playing short term trade presuming positive news in a week or two. Shares would return to the range highs near $37.00 Ex-Dividend Date later this week

GSK (GSK) Outperformed Market Returns In the latest trading session, GSK (GSK) closed at $37.10, marking a +1.23% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq added 0.39%. Prior to today's trading, shares of the dru

GSK looking bullish! Buy volume at resistance at this point in the falling channel should help propel the price to an initial measured target if $47 which would be thr breakout point of an even bigger bullish macro setup.

GSK with a bullish outlook following its earnings #Stocks The PEAD projected a bullish outlook for GSK after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 80%.

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Neutral

Neutral

Neutral

An aggregate view of professional's ratings.

Neutral

Neutral

Neutral

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds

Maturity dateApr 10, 2042

Coupon5.25% (Fixed)

Maturity dateSep 15, 2056

Coupon6.00% (Fixed)

Maturity dateMar 18, 2043

Coupon4.20% (Fixed)

Maturity dateMar 9, 2039

Coupon6.38% (Fixed)

Maturity dateMay 15, 2038

Coupon6.38% (Fixed)

Maturity dateMay 12, 2035

Coupon1.63% (Fixed)

Maturity dateSep 15, 2036

Coupon5.50% (Fixed)

Maturity dateApr 15, 2035

Coupon4.88% (Fixed)

Maturity dateSep 15, 2033

Coupon5.25% (Fixed)

Maturity dateSep 15, 2031

Coupon5.00% (Fixed)

Maturity dateDec 19, 2033

Coupon5.25% (Fixed)

See all GSK bonds

ETFs holding the stock

Weight0.35%

Market value‪66.96 M‬

Weight0.46%

Market value‪52.37 M‬

Weight4.40%

Market value‪44.47 M‬

Weight0.39%

Market value‪29.47 M‬

Weight2.33%

Market value‪15.27 M‬

Weight0.89%

Market value‪14.24 M‬

Weight0.10%

Market value‪12.88 M‬

Weight0.53%

Market value‪10.69 M‬

Weight4.43%

Market value‪10.51 M‬

Weight4.43%

Market value‪10.51 M‬

Weight4.43%

Market value‪10.51 M‬

Explore more ETFs